Showing results (1101-1110 of 1,128) with videos related to

Sort By:
Pageof 113
Nature Communications|May 11, 2024
Highest fusion performance without harmful edge energy bursts in tokamakS K Kim, R Shousha, S M Yang, et al.
JB & JS Open Access|June 25, 2025
Accuracy and Reliability of Video-Based Range-of-Motion Assessments in Postreconstruction Brachial Plexus PatientsChristopher J Dy, Stephen J DeMartini, Eshan Sane, et al.
JAMA Oncology|September 4, 2020
Efficacy and Safety of Pembrolizumab or Pembrolizumab Plus Chemotherapy vs Chemotherapy Alone for Patients With First-line, Advanced Gastric Cancer: The KEYNOTE-062 Phase 3 Randomized Clinical TrialKohei Shitara, Eric Van Cutsem, Yung-Jue Bang, et al.
Journal for Immunotherapy of Cancer|January 30, 2026
Clinical and translational results from a phase 1 trial of gemcitabine/nab-paclitaxel with nivolumab/ipilimumab or hydroxychloroquine/ipilimumab in untreated metastatic pancreatic adenocarcinomaEileen M O'Reilly, Christopher R Cabanski, Jaclyn P Lyman, et al.
Seminars in Cancer Biology|October 11, 2015
Dysregulated metabolism contributes to oncogenesisMatthew D Hirschey, Ralph J DeBerardinis, Anna Mae E Diehl, et al.
JAMA Oncology|March 16, 2018
Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer: Phase 2 Clinical KEYNOTE-059 TrialCharles S Fuchs, Toshihiko Doi, Raymond W Jang, et al.
Scientific Reports|March 7, 2013
Systematic repression of transcription factors reveals limited patterns of gene expression changes in ES cellsAkira Nishiyama, Alexei A Sharov, Yulan Piao, et al.
Cancer Cell|June 13, 2020
Unbiased Proteomic Profiling Uncovers a Targetable GNAS/PKA/PP2A Axis in Small Cell Lung Cancer Stem CellsGarry L Coles, Sandra Cristea, James T Webber, et al.
Cell Stem Cell|October 3, 2009
Uncovering early response of gene regulatory networks in ESCs by systematic induction of transcription factorsAkira Nishiyama, Li Xin, Alexei A Sharov, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 15, 2022
Adjuvant <i>nab</i>-Paclitaxel + Gemcitabine in Resected Pancreatic Ductal Adenocarcinoma: Results From a Randomized, Open-Label, Phase III TrialMargaret A Tempero, Uwe Pelzer, Eileen M O'Reilly, et al.
Pageof 113